ANDREA BOURKE: Open Payments
NPI 1194070466 · LONDONDERRY, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,408 in 43 payments from 16 companies in 2025. Trend: 2023 $1,874 · 2024 $1,223 · 2025 $1,408
Food & beverage: $1,339Education: $69
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $332 |
| UCB, Inc. | 5 | $135 |
| ABBVIE INC. | 5 | $120 |
| Organon LLC | 1 | $115 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 6 | $115 |
| Arcutis Biotherapeutics, Inc. | 1 | $109 |
| LEO Pharma Inc. | 4 | $89 |
| GENZYME CORPORATION | 1 | $83 |
| Incyte Corporation | 3 | $68 |
| Verrica Pharmaceuticals Inc. | 3 | $56 |
Products named: TREMFYA, Bimzelx, VTAMA, Zoryve, Cabtreo, DUPIXENT, SKYRIZI, OPZELURA.
Industry payments across NH — which companies pay providers there.
